Enter your login e-mail to the account
Search
- The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - HODGKIN’S LYMPHOMA
MUDr. Veronika Ballová
(2/2008, Review articles ) - Classical and new prognostic factors and their impact on therapeutic procedures in DLBCL
doc. MUDr. Igor Andrašina, CSc., MUDr. Martin Petrilák
(3/2015, Spectrum ) - Pixantrone in the treatment of relapsed/refractory aggressive B-non Hodgkin›s lymphomas: a retrospective data analysis
MUDr. Radoslav Greksák, PhD., MUDr. Miriam Ladická, doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM
(1/2023, Original articles ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Third line treatment in a patient over 60 years of age with the refractory/relapsed aggressive B-non Hodgkin’s lymphoma type DLBCL
MUDr. Radoslav Greksák, PhD.
(6/2020, Case reports ) - Relapsed/refractory diffuse large B-cell lymphoma
MUDr. Miriam Ladická
(4/2015, Spectrum ) - Advances in the treatment of T-cell lymphomas
MUDr. Lucia Petríková, PhD., MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(6/2022, Main topic ) - Large B-cell lymphomas – paradigm 2024
MUDr. Tomáš Guman, PhD., MBA, MUDr. Ján Sýkora
(1/2024, Main topic ) - Current indications of CAR T-cell therapy
MUDr. Andrej Vranovský, PhD., doc. MUDr. Alexandra Kolenová, PhD.
(1/2021, Review articles ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )